Crystal structures of zidovudine- or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215

被引：52
|
作者：
Chamberlain, PP
Ren, J
Nichols, CE
Douglas, L
Lennerstrand, J
Larder, BA
Stuart, DI
Stammers, DK
机构：
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England
[2] Oxford Ctr Mol Sci, Oxford OX1 3QT, England
[3] Visible Genet, Cambridge CB4 0GA, England
来源：
JOURNAL OF VIROLOGY | 2002年 / 76卷 / 19期
关键词：
D O I：
10.1128/JVI.76.19.10015-10019.2002
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70P, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.
引用
收藏
页码：10015 / 10019
页数：5
相关论文
共 50 条
  • [41] POL MUTATIONS CONFERRING ZIDOVUDINE AND DIDANOSINE RESISTANCE WITH DIFFERENT EFFECTS IN-VITRO YIELD MULTIPLY RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES IN-VIVO
    ERON, JJ
    CHOW, YK
    CALIENDO, AM
    VIDELER, J
    DEVORE, KM
    COOLEY, TP
    LIEBMAN, HA
    KAPLAN, JC
    HIRSCH, MS
    DAQUILA, RT
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) : 1480 - 1487
  • [42] Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1
    Hsu, ML
    Inouye, P
    Rezende, L
    Richard, N
    Li, Z
    Prasad, VR
    Wainberg, MA
    NUCLEIC ACIDS RESEARCH, 1997, 25 (22) : 4532 - 4536
  • [43] Antiviral activity of 2′-deoxy-3′-oxa-4′-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice
    Stoddart, CA
    Moreno, ME
    Linquist-Stepps, VD
    Bare, C
    Bogan, MR
    Gobbi, A
    Buckheit, RW
    Bedard, J
    Rando, RF
    McCune, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 783 - 786
  • [44] Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations
    Oliveira, Maureen
    Moisi, Daniela
    Spira, Bonnie
    Cox, Susan
    Brenner, Bluma G.
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1683 - 1685
  • [45] Human Immunodeficiency Virus Type 1 Recombinant Reverse Transcriptase Enzymes Containing the G190A and Y181C Resistance Mutations Remain Sensitive to Etravirine
    Xu, Hongtao
    Quan, Yudong
    Brenner, Bluma G.
    Bar-Magen, Tamara
    Oliveira, Maureen
    Schader, Susan M.
    Wainberg, Mark A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4667 - 4672
  • [46] Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine
    deJong, MD
    Veenstra, J
    Stilianakis, NI
    Schuurman, R
    Lange, JMA
    deBoer, RJ
    Boucher, CAB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (11) : 5501 - 5506
  • [47] Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRFO1_AE (Subtype E) human immunodeficiency virus type
    Myint, L
    Ariyoshi, K
    Yan, H
    Frater, AJ
    Auwanit, W
    Pathipvanith, P
    Yamada, K
    Matsuda, M
    Chiba, T
    Fujita, K
    McClure, M
    Weber, JN
    Sugiura, W
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) : 3861 - 3868
  • [48] Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val
    Sharma, PL
    Crumpacker, CS
    JOURNAL OF VIROLOGY, 1999, 73 (10) : 8448 - 8456
  • [49] Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of Stavudine and zidovudine and its inhibition by efavirenz
    Crespan, E
    Locatelli, GA
    Cancio, R
    Hübscher, U
    Spadari, S
    Maga, G
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) : 342 - 349
  • [50] Human immunodeficiency virus (HIV) type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine
    Delaugerre, C
    Marcelin, AG
    Thibault, V
    Peytavin, G
    Bombled, T
    Bochet, MV
    Katlama, C
    Benhamou, Y
    Calvez, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1586 - 1588
12345